Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain- Cost of Achieving Composite Endpoints
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2110
https://www.valueinhealthjournal.com/article/S1098-3015(15)04186-8/fulltext
Title :
Economics Analysis of Dapagliflozin Compare to Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus in Spain- Cost of Achieving Composite Endpoints
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04186-8&doi=10.1016/j.jval.2015.09.2110
First page :
A609
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1525